Postmenopausal hormone-replacement therapy - Time for a reappraisal?

New England Journal of Medicine

Volumn 336, Issue 25, 1997, Pages 1821-1822

  Brinton, L A ^a   Schairer, S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

BREAST CANCER; CANCER MORTALITY; CANCER RISK; CAUSE OF DEATH; EDITORIAL; FEMALE; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS;

BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MORTALITY; NEOPLASMS; POSTMENOPAUSE; PROGESTINS; RISK;

EID: 0030898871     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199706193362509     Document Type: Editorial

References (15)